JF
AMRX icon

Jump Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Jump Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,370
Closed -$303K – 1997
2026
Q1 		$303K Sell
24,370
-212,025
-90% -$2.85M ﹤0.01% 1477
2025
Q4 		$2.98M Sell
236,395
-68,202
-22% -$780K 0.04% 534
2025
Q3 		$3.05M Buy
304,597
+43,747
+17% +$393K 0.04% 568
2025
Q2 		$2.11M Buy
260,850
+46,475
+22% +$350K 0.02% 707
2025
Q1 		$1.8M Buy
214,375
+48,459
+29% +$404K 0.02% 614
2024
Q4 		$1.31M Buy
+165,916
New +$1.39M 0.03% 652
2024
Q2 		– Sell
-30,995
Closed -$188K – 1776
2024
Q1 		$188K Sell
30,995
-35,105
-53% -$198K 0.01% 1700
2023
Q4 		$401K Sell
66,100
-8,700
-12% -$38.8K 0.01% 1183
2023
Q3 		$316K Buy
+74,800
New +$279K 0.01% 1274
2022
Q4 		– Sell
-52,300
Closed -$105K – 1543
2022
Q3 		$105K Buy
+52,300
New +$147K ﹤0.01% 1439
2022
Q2 		– Sell
-18,200
Closed -$76K – 1593
2022
Q1 		$76K Sell
18,200
-8,600
-32% -$38.1K ﹤0.01% 1438
2021
Q4 		$129K Buy
26,800
+9,900
+59% +$49.4K 0.01% 1191
2021
Q3 		$90K Buy
+16,900
New +$85.1K 0.01% 982

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Jump Financial's AMRX Position: Q2 2026 in Review

Jump Financial sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 24,370 shares — an estimated $303K sold.

Jump Financial first reported a position in AMRX in Q3 2021 and held it in 13 quarters. The position peaked at $3.05M in Q3 2025. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Jump Financial reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 24,370 Amneal Pharmaceuticals shares in Q2 2026, an estimated $303K.
  • Jump Financial first reported a position in Amneal Pharmaceuticals in Q3 2021 and held it in 13 quarters.
  • Jump Financial's Amneal Pharmaceuticals position peaked at $3.05M in Q3 2025.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.